Engineering of living cells for the expression of holo-phycobiliprotein-based constructs
CA 2454899 A1 · Owner: Cai, Yuping · Inventors: Tooley, Aaron J.; Glazer, Alexander N.; Cai, Yuping
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Recombinant cells which express a fluorescent holo-phycobiliprotein fusion protein and methods of use are described. The cells comprises a bilin a , recombinant bilin reductase, an apo-phycobiliprotein fusion protein precursor of the fusion protein comprising a corresponding apo-phycobiliprotein domain and a recombinant phycobiliprotein domain-bilin lyase which components react , to form the holo-phycobiliprotein fusion protein. Also described are holophycobiliprotein based transcription reporter cells and assays which cells , conditionally express a heterologous-to-the-cell fluorescent, first holo-, phycobiliprotein domain.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 30, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 30, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 30, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.